Document Classification

Section Type: METHODS

Text: Children with recurrent/refractory sarcoma were treated with ifosfamide (1, 800 mg/m2/day on day 0-4), carboplatin (400 mg/m2/day on day 0-1), etoposide (100 mg/m2/day on day 0-4) and either rhG-CSF (10 microg/kg/day vs. 5 microg/kg/day, CCG-0894, 71 patients), PIXY321 (500-1, 000 microg/m2/day, CCG-0924, 14 patients), or rhG-CSF (5 microg/kg/day) and IL-6 (2. 5-5 microg/kg/day, CCG-0931, 12 patients).